<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li C</submitter><funding>Natural Science Foundation of Shandong Province</funding><funding>NCI NIH HHS</funding><pagination>628-639</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6644699</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>79(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Alternol is a natural compound isolated from fermentation products of a mutant fungus. Our previous studies demonstrated that Alternol specifically kills cancer cells but spares benign cells.&lt;h4>Methods&lt;/h4>To investigate the mechanism underlying alternol-induced cancer cell-specific killing effect, we took a comprehensive strategy to identify Alternol's protein targets in prostate cancer cells, including PC-3, C4-2, and 22RV1, plus benign BPH1 cell lines. Major experimental techniques included biotin-streptavidin pulldown assay coupled with mass-spectrometry, in vitro enzyme activity assay for Krebs cycle enzymes and gas chromatography-mass spectrometry (GC-MS) for metabolomic analysis.&lt;h4>Results&lt;/h4>Among 14 verified protein targets, four were Krebs cycle enzymes, fum</pubmed_abstract><journal>The Prostate</journal><pubmed_title>Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer.</pubmed_title><pmcid>PMC6644699</pmcid><funding_grant_id>ZR2016HL25</funding_grant_id><funding_grant_id>R01 CA173292</funding_grant_id><pubmed_authors>He C</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Krishnamurthy P</pubmed_authors><pubmed_authors>Chavan H</pubmed_authors><pubmed_authors>Holzbeierlein JM</pubmed_authors><pubmed_authors>Xu H</pubmed_authors><pubmed_authors>Han S</pubmed_authors><pubmed_authors>Forrest ML</pubmed_authors><pubmed_authors>Duan S</pubmed_authors><pubmed_authors>Artigues A</pubmed_authors><pubmed_authors>Li B</pubmed_authors><pubmed_authors>Tang Y</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer.</name><description>&lt;h4>Background&lt;/h4>Alternol is a natural compound isolated from fermentation products of a mutant fungus. Our previous studies demonstrated that Alternol specifically kills cancer cells but spares benign cells.&lt;h4>Methods&lt;/h4>To investigate the mechanism underlying alternol-induced cancer cell-specific killing effect, we took a comprehensive strategy to identify Alternol's protein targets in prostate cancer cells, including PC-3, C4-2, and 22RV1, plus benign BPH1 cell lines. Major experimental techniques included biotin-streptavidin pulldown assay coupled with mass-spectrometry, in vitro enzyme activity assay for Krebs cycle enzymes and gas chromatography-mass spectrometry (GC-MS) for metabolomic analysis.&lt;h4>Results&lt;/h4>Among 14 verified protein targets, four were Krebs cycle enzymes, fum</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 May</publication><modification>2026-05-04T23:37:41.279Z</modification><creation>2020-10-29T14:04:58Z</creation></dates><accession>S-EPMC6644699</accession><cross_references><pubmed>30663084</pubmed><doi>10.1002/pros.23767</doi></cross_references></HashMap>